定义皮肤鳞状细胞癌中癌症相关基质的分子景观
研究对20例皮肤鳞状细胞癌(11例无神经周围浸润、9例有神经周围浸润)的癌症相关基质与匹配正常基质行激光捕获显微切割联合RNA测序,发现基质广泛重编程且由免疫细胞变化驱动,基质显示免疫耗竭标志,PD-L1表达于NK T细胞可能促T细胞耗竭;神经周围浸润者IL-17A升高且成纤维细胞贡献增加、FAP+细胞显著增多。
要点
- 皮肤鳞状细胞癌癌症相关基质存在广泛重编程,主要由免疫细胞变化驱动。
- 癌症相关基质显示免疫耗竭标志,PD-L1表达于NK T细胞可能促T细胞耗竭与免疫抑制。
- 神经周围浸润病例以IL-17A升高为特征,成纤维细胞贡献增加且FAP+细胞显著增多。
核心结论
- 研究阐明了皮肤鳞状细胞癌癌症相关基质的分子景观并识别免疫抑制机制,支持进一步研究免疫治疗与抗IL-17A治疗皮肤鳞状细胞癌,尤其针对神经周围浸润病例。
研究设计与样本
- 对20例皮肤鳞状细胞癌病例(11例无神经周围浸润、9例有神经周围浸润)的癌症相关基质与匹配正常基质行激光捕获显微切割联合RNA测序,并用免疫组化验证。
主要发现
- 分析揭示癌症相关基质广泛重编程,且主要由免疫细胞变化驱动并经免疫组化验证。
- 皮肤鳞状细胞癌癌症相关基质显示免疫耗竭标志,多重空间分析提示NK T细胞上的PD-L1表达促T细胞耗竭与免疫抑制。
- 神经周围浸润以IL-17A升高为特征;无神经周围浸润病例中IL-17A主要来自CD3+细胞,伴神经周围浸润时成纤维细胞对高IL-17A的贡献增加,并伴随FAP+细胞显著增多。
临床怎么用
- 原文结论支持进一步研究免疫治疗与抗IL-17A治疗皮肤鳞状细胞癌,尤其针对神经周围浸润病例。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer worldwide. Cancer-associated stroma (CAS) is central to tumor development and strongly influences therapy response. Perineural infiltration (PNI) represents a major risk factor for cSCC and likely influences CAS reprogramming. However, stromal reprogramming in cSCC remains poorly characterized, and it is unknown whether and how PNI influences CAS. To address these questions, we analyzed CAS and matched normal stroma from 20 cSCC cases (11 without PNI and 9 with PNI) by laser-capture microdissection using RNA sequencing. Our analysis reveals extensive stromal reprogramming strongly driven by changes in immune cells, as validated using immunohistochemistry. Furthermore, CAS of cSCC displays markers of immune exhaustion, and multiplex spatial analysis suggests that PD-L1 expression on NK T cells contributes to T-cell exhaustion and immunosuppression. Finally, PNI is characterized by increased IL-17A. In PNI-negative cases, IL-17A derives predominantly from CD3+ cells. However, with PNI, we observe an increased contribution of fibroblasts to high IL-17A, which coincides with a significant increase in FAP+ cells. Our analysis elucidates the molecular landscape of CAS in cSCC and identifies the presence of immunosuppressive mechanisms, supporting further research into immunotherapy and anti‒IL-17A in cSCC, especially for cases with PNI.
引用
- Beebe E, Motamed Z, Opitz L, et al. Defining the Molecular Landscape of Cancer-Associated Stroma in Cutaneous Squamous Cell Carcinoma. J Invest Dermatol. 2022. PMID: 35850206. doi:10.1016/j.jid.2022.06.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。